Rupinta, Edelyn Faye T.

HRN: 17-33-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2023
CEFUROXIME 1.5GM (VIAL)
11/18/2023
11/19/2023
IV
1.5grams
PTOR
For Elective Repeat CS With BTL
Checking Final Appropriateness 
11/18/2023
CEFUROXIME 1.5GM (VIAL)
11/18/2023
11/19/2023
IV
1.5 Gm
Q 8h
S/P Repeat LTCS W/ BTL
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: